ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Pfizer, Inc.
(NY:
PFE
)
29.40
USD
UNCHANGED
Official Closing Price
/ Updated:
6:40 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Pfizer, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Interesting Similarities Among 2013's Top-Performing ETFs
June 18, 2013
With 2013 nearly half complete, now is a good time to look at this year's top-performing ETFs to see what has worked, what might keep working and which funds could be vulnerable to second-half...
Read More
category
Specialty ETFs
,
Benzinga
,
PBE
, and 24 more.
from
Latest Articles from Benzinga.com
Tuesday's ETF with Unusual Volume: IWX
June 18, 2013
The iShares Russell Top 200 Value Index Fund (IWX) is seeing unusually high volume in afternoon trading Tuesday, with over 207,000 shares traded versus three month average volume of about 41,000....
Read More
category
ETFs
from
ETF Channel
Worst Performing Dow Component: Procter
June 18, 2013
New York, June 18th (TradersHuddle.com) - The Dow Jones Industrial Average is higher trading at 15287.7, which represents 0.71% versus its previous trading session close, with only one of its component...
Read More
from
TradersHuddle.com
The NIH Aims To Develop Drugs That Big Pharma Discarded
June 18, 2013
This morning, the National Institutes of Health awarded $12.7 million to nine academic groups to test potential medicines for diseases including Alzheimer's disease, Duchenne muscular dystrophy, and...
Read More
category
NYSE:JNJ
,
NASDAQ:CBST
,
NYSE:PFE
, and 2 more.
from
Forbes Real Time
Supreme Court Permits Antitrust Scrutiny Of Pharma Settlements
June 18, 2013
In a ruling that is likely to have a far-reaching impact on the pharmaceutical industry, the Supreme Court permitted antitrust scrutiny of reverse pay settlements used between brand name drug makers...
Read More
category
NYSE:MRK
,
NYSE:PFE
,
NYSE:BMY
, and 1 more.
from
Forbes Real Time
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
June 18, 2013
category
Pharmaceuticals
from
Trefis
Strategy Behind Our Success, We Get in Early: AAPL, PFE, GOOG and MSFT
June 18, 2013
from
Marketwired News Releases
Court Appoints Lead Plaintiff in Shareholder Lawsuit Against SAC
June 17, 2013
A New York court designated a pension fund as the lead plaintiff in a lawsuit filed by shareholders of Elan against SAC Capital.
Read More
from
FOX News
Court appoints lead plaintiff in shareholder lawsuit against SAC
June 17, 2013
June 18 (Reuters) - A New York court designated a pension fund as the lead plaintiff in a lawsuit filed by shareholders of Elan Corp against SAC Capital, a court filing showed, as the hedge fund...
Read More
category
companyNews
from
Reuters: Company News
pSivida stock rises after being named as a takeover target
June 17, 2013
Stock in pSivida Corp. (Nasdaq: PSDV) rose 9 percent Monday after its treatment for some types of chronic diabetic macular edema (DME) was deemed cost effective by a UK agency, and the company was...
Read More
category
Paul Ashton
,
Watertown
,
Biotech
, and 6 more.
from
Business Journals
Pharma Stocks: Court Ruling's Real Meaning
June 17, 2013
category
AZN
,
SNY
,
MRK
, and 4 more.
from
YCharts
Worst Performing Dow Component: Pfizer
June 17, 2013
New York, June 17th (TradersHuddle.com) - The Dow Jones Industrial Average is higher trading at 15232, which represents 1.07% versus its previous trading session close, with only two of its components...
Read More
from
TradersHuddle.com
Supreme Court Ruling Creates Uncertainly for Drug Makers (ACT) (MYL) (MRK)
June 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8422776 for the full story.
Read More
from
StreetInsider.com News Articles
Datawatch to buy Swedish software biz, ‘cool vendor’ in deal worth $31.4M
June 17, 2013
Building on its strategy to boost partnerships and securing deals with more than 18 new partners this year, Datawatch Corp...
Read More
category
Gartner Inc/
,
Citigroup
,
Michael Morrison
, and 7 more.
from
Business Journals
News Behind Insider Trading for Walter Energy, American Express, Charles Schwab, Groupon, Pfizer, and Fannie Mae
June 17, 2013
from
PR Newswire
InSite Vision Announces Joint Patent Infringement Lawsuit with Merck Against Mylan Pharmaceuticals
June 17, 2013
from
Business Wire News Releases
BCG Weighs In On First-In-Class Vs. Best-In-Class Drugs -- How Valuable Is Their Advice?
June 17, 2013
The hardest decisions facing a head of a pharmaceutical R&D organization involve determining which great ideas to fund. One might think this is a simple process, that any idea which can lead to a new...
Read More
category
NYSE:PFE
,
NYSE:BMY
from
Forbes Real Time
Litigation Settlements, Data Compliance Reviews, and Clinical Trials Pave Way for Solid Footing in Healthcare - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Keryx and Pacira Pharmaceuticals
June 17, 2013
Editor Note: For more information about this release, please scroll to bottom
Read More
from
PR Newswire
Pfizer - Roundup Review
June 17, 2013
NEW YORK (AVAFIN) -- Block trades serve as a useful indicator for investors trying ...
Read More
from
AVAFIN
Before the Crowd, How We Found AAPL, PFE, GOOG and MSFT
June 17, 2013
from
Marketwired News Releases
UK scientists win funding for new kind of anticoagulant drug
June 16, 2013
LONDON, June 17 (Reuters) - British scientists have won early financial backing for a new kind of anticoagulant drug they believe may prevent dangerous blood clots without causing bleeding - a...
Read More
category
companyNews
from
Reuters: Company News
Zoetis Set to Join S&P 500; First Horizon National to Join S&P MidCap 400; QLogic to Join S&P SmallCap 600
June 14, 2013
from
PR Newswire
Friday's ETF with Unusual Volume: XPH
June 14, 2013
The SPDR S&P Pharmaceuticals ETF (XPH) is seeing unusually high volume in afternoon trading Friday, with over 119,000 shares traded versus three month average volume of about 40,000. Shares of XPH were...
Read More
category
ETFs
from
ETF Channel
DOW JONES STOCKS REPORTING NEWS: Exxon Mobil Corporation, General Electric Company, Pfizer, Inc., Verizon Communications Inc.
June 14, 2013
Huntington Beach, CA -- (SBWIRE) -- 06/14/2013 -- PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued,...
Read More
from
SBWire - Latest Press Releases
TradersHuddle Dow's Update, In focus:VZ, PFE, TRV, DD, AXP
June 14, 2013
New York, June 14th (TradersHuddle.com) - The Dow Jones Industrial Average is lower trading at 15100.3, which represents -0.5% versus its previous trading session close, With only 8 of its components...
Read More
from
TradersHuddle.com
BioLabs' shareholder questions ROI
June 14, 2013
Jeffrey Chokel, a longtime Cleveland BioLabs Inc. shareholder from Shaker Heights, Ohio, cut right to the chase at the company’s annual shareholder meeting Friday morning...
Read More
category
Cleveland BioLabs Inc/
,
Julia Brown
,
David Hohn
, and 11 more.
from
Business Journals
Above Resistance: Pfizer
June 14, 2013
New York, June 14th (TradersHuddle.com) - Shares of Pfizer, Inc. ( NYSE:PFE ) closed the session at $29.08 just above calculated resistance at $28.62. The stock moved to what appears to be a higher...
Read More
from
TradersHuddle.com
Don't Miss Gains in BAC, SIRI, S and PFE
June 14, 2013
from
Marketwired News Releases
NYSE MOST ACTIVES: Bank of America Corporation, Ford Motor Company, Pfizer, Inc., Sprint Nextel Corporation
June 13, 2013
Huntington Beach, CA -- (SBWIRE) -- 06/13/2013 -- PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued,...
Read More
from
SBWire - Latest Press Releases
For Love and Money: Three Growth Stocks from Casey’s Alex Daley
June 13, 2013
category
Pharmaceuticals
,
Medical Devices & Supplies
from
Trefis
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
2
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
3
Why Apple Inc. Can't Be Forgiven for iOS 7
Mike Schuster
4
What Now, Mr. Bernanke? Traders Position Into the FOMC Rate Decision
Todd Harrison
5
In Insider Trading, Phillip Frost Increases Stake in Opko Health Inc. and Larry Page Sells Shares of Google Inc
Jonathan Moreland
See All Articles
»